Clinical trials
Lymphoma, Mantle-Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 10 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 10 |
| 2025 | 14 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
| Unknown status | 26 |
| Completed | 15 |
| Active, not recruiting | 12 |
| Not yet recruiting | 9 |
| Terminated | 5 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeOne Medicines | 5 |
| Chinese PLA General Hospital | 5 |
| Peking University Third Hospital | 5 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 5 |
| Ruijin Hospital | 5 |
| Sun Yat-sen University | 5 |
| Guangzhou Lupeng Pharmaceutical Company LTD. | 4 |
| AstraZeneca | 3 |
| BeiGene | 3 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Mantle-Cell | 94 |
| Lymphoma, Large B-Cell, Diffuse | 34 |
| Lymphoma, Follicular | 32 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 27 |
| Lymphoma, B-Cell | 13 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
| Lymphoma, Non-Hodgkin | 10 |
| Recurrence | 10 |
| Hematologic Neoplasms | 8 |
| Lymphoma | 6 |
Trials
Showing 51 to 75 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.